← Open Payments lookup

ADAM CLAY: Open Payments

NPI 1265881007 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,304 in 99 payments from 19 companies in 2025. Trend: 2023 $703 · 2024 $1,175 · 2025 $2,304

Food & beverage: $2,255Education: $50
CompanyPaymentsAmount
PFIZER INC.24$369
Philips North America LLC12$240
Bayer Healthcare Pharmaceuticals Inc.9$233
Alnylam Pharmaceuticals Inc.5$188
E.R. Squibb & Sons, L.L.C.6$176
Merck Sharp & Dohme LLC8$173
Amgen Inc.6$148
AstraZeneca Pharmaceuticals LP3$126
Abbott Laboratories2$116
Inspire Medical Systems, Inc.3$109

Products named: Kerendia, Ambulatory Monitoring & Diagnostics Undivided, VYNDAQEL, AMVUTTRA, ELIQUIS, CAMZYOS, VERQUVO, REPATHA.

Industry payments across MS — which companies pay providers there.